Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin

Obesity Research

Volumn 11, Issue 12, 2003, Pages 1463-1470

  Bagnasco, Michela ^a   Dube, Michael G ^b   Katz, Adi ^a   Kalra, Pushpa S ^b   Kalra, Satya P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Dietary obesity; Gene therapy; Hyperinsulinemia; Leptin; Paraventricular nucleus

Indexed keywords

CARRIER PROTEIN; FATTY ACID; GHRELIN; ION CHANNEL; LEPTIN; MEMBRANE PROTEIN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; PEPTIDE HORMONE;

ADENOVIRUS; ANIMAL; ANTERIOR HYPOTHALAMUS; ARTICLE; BIOSYNTHESIS; BLOOD; BROWN ADIPOSE TISSUE; EATING; FAT INTAKE; FEMALE; GENE THERAPY; GENE VECTOR; GENETICS; HYPERINSULINISM; METABOLISM; METHODOLOGY; MICROINJECTION; OBESITY; PHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; ADIPOSE TISSUE, BROWN; ANIMALS; CARRIER PROTEINS; DIETARY FATS; EATING; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE THERAPY; GENETIC VECTORS; HYPERINSULINISM; ION CHANNELS; LEPTIN; MEMBRANE PROTEINS; MICROINJECTIONS; MITOCHONDRIAL PROTEINS; OBESITY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PEPTIDE HORMONES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 2142687620     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.196     Document Type: Conference Paper

References (53)

1. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104:531-43.
2. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science. 2003;299:853-5.
3. Pi-Sunyer X. A clinical view of the obesity problem. Science. 2003;299:859-60.
4. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev. 1999;20:68-100.
5. Ahima RS, Saper CB, Flier JS, Elmquist JK. Leptin regulation of neuroendocrine systems. Front Neuroendocrinol. 2000;21:263-307.
6. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5.
7. Pu S, Dube MG, Kalra PS, Kalra SP. Regulation of leptin secretion: effects of aging on daily patterns of serum leptin and food consumption. Regul Pept. 2000;92:107-11.
8. Kastin AJ, Pan W. Dynamic regulation of leptin entry into brain by the blood-brain barrier. Regul Pept. 2000;92:37-43.
9. Banks WA, DiPalma CR, Farrell CL. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides. 1999;20:1341-5.
10. Burguera B, Couce ME, Curran GL, et al. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes. 2000;49:1219-23.
11. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest. 2000;105:1827-32.
12. Dhillon H, Kalra SP, Prima V, et al. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regul Pept. 2001;99:69-77.
13. Dhillon H, Kalra SP, Kalra PS. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol Ther. 2001;4:139-45.
14. Beretta E, Dube MG, Kalra PS, Kalra SP. Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes. Ped Res. 2002;52:189-98.
15. Bagnasco M, Dube MG, Kalra PS, Kalra SP. Evidence for the existence of distinct central appetite and energy expenditure pathways and stimulation of ghrelin as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology. 2002;143:4409-21.
16. Dube MG, Beretta E, Dhillon H, Ueno N, Kalra PS, Kalra SP. Central leptin gene therapy blocks high fat diet-induced weight gain, hyperleptinemia and hyperinsulinemia: effects on serum ghrelin levels. Diabetes. 2002;51:1729-36.
17. Samulski RJ, Sally M, Muzyczka N. Adeno-associated viral vectors. In: Friedman T, ed. The Development of Human Gene Therapy. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1999, pp. 131-72.
18. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci. 1998;18:559-72.
19. Diano S, Kalra SP, Sakamoto H, Horvath TL. Leptin receptors in estrogen receptor-containing neurons of the female rat hypothalamus. Brain Res. 1998;812:256-9.
20. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 1996;387:113-6.
21. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol. 1998;395:535-47.
22. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci. 1998;1:445-50.
23. Burguera B, Couce ME, Long J, et al. The long form of the leptin receptor (OB-Rb) is widely expressed in the human brain. Neuroendocrinology. 2000;71:187-95.
24. Yokosuka M, Xu B, Pu S, Kalra PS, Kalra SP. Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake. Physiol Behav. 1998;64:331-8.
25. Kalra SP, Kalra PS. Hypothalamic regulation of appetite and obesity. In: Martini L, ed. Encyclopedia of Endocrinology and Endocrine Diseases. San Diego, CA: Academic Press; 2003 (in press).
26. Friedman JM. A war on obesity, not the obese. Science. 2003;299:856-8.
27. Lowell BB, Spiegelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature. 2000;404:652-60.
28. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;269:540-3.
29. Dhillon H, Ge Y, Minter RM, et al. Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change. Regul Pept. 2000;92:97-105.
30. Morash B, Li A, Murphy PR, Wilkinson M, Ur E. Leptin gene expression in the brain and pituitary gland. Endocrinology. 1999;140:5995-8.
31. Wiesner G, Vaz M, Collier G, et al. Leptin is released from the human brain: influence of adiposity and gender. J Clin Endocrinol Metab. 1999;84:2270-4.
32. Fuxe K, Agnati LH. Advances in neurosciences. In: Fuxe K, Agnati LH, eds. Volume Transmission in the Brain, Novel Mechanisms for Neural Ttransmission. New York: Raven Press; 1991, pp. 1-602.
33. Nicholson C, Rice ME. Diffusion of ions and transmitters in the brain cell microenvironment. In: Fuxe K, Agnati LH, eds. Novel Mechanisms for Neuronal Transmission. Advances in Neuroscience. New York: Raven Press; 1991, pp. 279-94.
34. Xu B, Li BH, Rowland NE, Kalra SP. Neuropeptide Y injection into the fourth cerebroventricle stimulates c- Fos expression in the paraventricular nucleus and other nuclei in the forebrain: effect of food consumption. Brain Res. 1995;698:227-31.
35. Li BH, Xu B, Rowland NE, Kalra SP. c-fos expression in the rat brain following central administration of neuropeptide Y and effects of food consumption. Brain Res. 1994;665:277-84.
36. Grill HJ, Schwartz MW, Kaplan JM, Foxhall JS, Breininger J, Baskin DG. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology. 2002;143:239-46.
37. Hosoi T, Kawagishi T, Okuma Y, Tanaka J, Nomura Y. Brain stem is a direct target for leptin's action in the central nervous system. Endocrinology. 2002;143:3498-504.
38. 1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: evidence for a hypothalamic site for concurrent development of leptin resistance. J Neuroendocrinol. 1998;10:43-9.
39. Dube MG, Xu B, Kalra PS, Sninsky CA, Kalra SP. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Res. 1999;816:38-46.
40. Choi S, Sparks R, Clay M, Dallman MF. Rats with hypothalamic obesity are insensitive to central leptin injections. Endocrinology. 1999;140:4426-33.
41. Koyama K, Shimabukuro M, Chen G, et al. Resistance to adenovirally induced hyperleptinemia in rats. Comparison of ventromedial hypothalamic lesions and mutated leptin receptors. J Clin Invest. 1998;102:728-33.
42. Dhillon H. Effects of Recombinant Adeno-associated Virus Encoding Leptin on Body Weight Regulation and Energy Homeostasis. Ph.D. Dissertation, Gainesville, FL: University of Florida; 2000. http://etd.fcla.edu/etd/uf/2000/ ane5948/dissertation.PDF
43. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001;7:33-40.
44. Seisenberger G, Ried MU, Endress T, Buning H, Hallek M, Brauchle C. Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science. 2001;294:1929-32.
45. Kalra SP, Kalra PS. Keeping obesity and metabolic syndrome at bay with central leptin and cytokine gene therapy. In: Hamilton I, ed. Current Medicinal Chemistry - Central Nervous System Agents. San Francisco, CA: Bentham Science Publications Ltd.; 2003, pp. 189-99.
46. Ueno N, Dube MG, Kalra PS, Kalra SP. Central leptin gene therapy increases insulin sensitivity and suppresses weight without affecting food intake. 32nd Annual Society for Neuroscience Meeting, November 2-7, 2002, Orlando, FL. Society for Neuroscience; 2002, p. 781.52 (Abstr 573.9).
47. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473-81.
48. Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic B-cells. Am J Physiol Endocrinol Metab. 2000;278:E1-14.
49. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908-13.
50. Horvath TL, Diano S, Sotonyi P, Heiman M, Tschop M. Minireview: ghrelin and the regulation of energy balance - a hypothalamic perspective. Endocrinology. 2001;142:4163-9.
51. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol. 2002;440:235-54.
52. Ueno N, Dube MG, Katz A, Kalra PS, Kalra SP. Leptin inhibits ghrelin-induced obesity by two distinct central and peripheral mechanisms: effects on adiponectin. 33rd Annual Society for Neuroscience Meeting. Society for Neuroscience, November 8-12, 2003, New Orleans, LA. Society for Neuroscience; 2003, p. 81 (Abstr 283.8).
53. Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37:649-61.